Rathkopf, MD, of Memorial Sloan Kettering Cancer Center in New York, New York, and colleagues noted in a study abstract. In Part B of the CC-94676-PCA-001 trial (NCT04428788), the investigators tested ...

School meals are a critical safety net for health equity, since chronic diseases caused by poor nutrition disproportionately ...

Andrea Cercek, MD, a gastrointestinal oncologist at Memorial Sloan Kettering Cancer Center in New York, tells Self that for younger people with colon cancer, tumors often develop in the last portion ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Researchers found that blood samples collected during home phlebotomy visits met performance and quality standards.

It's been two years since Destiny Hannah received a bone marrow transplant to reverse her sickle cell disease. Once a patient ...

To address the unique needs of patients with graft-vs-host disease (GVHD), the bone marrow and stem cell transplant program ...

Enrollment of 68 patients completed Phase 2 study for eseba-vec + pembrolizumab in HPV+ HNSCC four months ahead of schedule ...

Led by Dr. Craig Thompson of Memorial Sloan Kettering Cancer Center, the study identified specific mitochondrial subpopulations, allowing cells to maintain critical functions even under stress. The ...

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE ... an enrolling Phase 2 trial in second-line and later-stage advanced gastroesophageal cancer at Memorial Sloan-Kettering Cancer Center, with results expected ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.